TP53 and cancer: Inhibition of TAp63 and p53 protects primordial oocytes from low-dose radiation and selected chemotherapies (24, 47, 72, 73, 80), but targeting transcription factors remains challenging and blocking apoptosis directly may pose an issue for cancer treatment and development of resistance to therapy.